xenpozyme
sanofi b.v. - olipudase alfa - acid sphingomyelinase deficiency (asmd) type a/b or type b - andre alimentary tract and metabolism produkter, - xenpozyme is indicated as an enzyme replacement therapy for the treatment of non-central nervous system (cns) manifestations of acid sphingomyelinase deficiency (asmd) in paediatric and adult patients with type a/b or type b.
enjaymo
sanofi b.v. - sutimlimab - hemolysis; anemia, hemolytic, autoimmune - immunosuppressiva - enjaymo is indicated for the treatment of haemolytic anaemia in adult patients with cold agglutinin disease (cad).
tepkinly
abbvie deutschland gmbh & co. kg - epcoritamab - lymphoma, large b-cell, diffuse - antineoplastiske midler - tepkinly as monotherapy is indicated for the treatment of adult patients with relapsed or refractory diffuse large b-cell lymphoma (dlbcl) after two or more lines of systemic therapy.
palladon 50 mg/ml injektions-/infusionsvæske, opløsning
mundipharma a/s - hydromorphonhydrochlorid - injektions-/infusionsvæske, opløsning - 50 mg/ml
hydromorphonhydrochlorid "kalceks" 10 mg/ml injektions-/infusionsvæske, opløsning
kalceks as - hydromorphonhydrochlorid - injektions-/infusionsvæske, opløsning - 10 mg/ml
hydromorphonhydrochlorid "kalceks" 20 mg/ml injektions-/infusionsvæske, opløsning
kalceks as - hydromorphonhydrochlorid - injektions-/infusionsvæske, opløsning - 20 mg/ml
hydofon 10 mg/ml injektions-/infusionsvæske, opløsning
2care4 generics aps - hydromorphonhydrochlorid - injektions-/infusionsvæske, opløsning - 10 mg/ml
hydofon 20 mg/ml injektions-/infusionsvæske, opløsning
2care4 generics aps - hydromorphonhydrochlorid - injektions-/infusionsvæske, opløsning - 20 mg/ml
hydofon 2 mg/ml injektions-/infusionsvæske, opløsning
2care4 generics aps - hydromorphonhydrochlorid - injektions-/infusionsvæske, opløsning - 2 mg/ml
hydofon 50 mg/ml injektions-/infusionsvæske, opløsning
2care4 generics aps - hydromorphonhydrochlorid - injektions-/infusionsvæske, opløsning - 50 mg/ml